Evidence map›Paper›PMID 28626570›Full record

ArticleChemical science2017

Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt

Silvia Alonso-de Castro, Emmanuel Ruggiero, Ane Ruiz-de-Angulo, Elixabete Rezabal, Juan C Mareque-Rivas, Xabier Lopez, Fernando López-Gallego, Luca Salassa

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of theAntioxidants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Transfer hydrogenation catalysis in cells.RSC chemical biology · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Biological activity of PtScientific reports · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Silvia Alonso-de CastroCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.
Emmanuel RuggieroCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.
Ane Ruiz-de-AnguloCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.
Elixabete RezabalFarmazia Fakultatea , Kimika Fisikoa Departamentua , Euskal Herriko Unibertsitatea , UPV/EHU , 01006 , Vitoria-Gasteiz , Spain.
Juan C Mareque-RivasCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.
Xabier LopezDonostia International Physics Center (DIPC) , P.K. 1072 , Donostia-San Sebastián , 20080 , Spain.
Fernando López-GallegoCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.
Luca SalassaCIC biomaGUNE , Paseo de Miramón 182 , Donostia-San Sebastián , 20014 , Spain.ORCID 0000-0002-2112-9095
CIC biomaGUNE · ESIkerbasque · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Encouraging developments demonstrate that few transition metal and organometallic catalysts can operate in a bioorthogonal fashion and promote non-natural chemistry in living systems by minimizing undesired side reactions with cellular components. These catalytic processes have potential for applications in medicinal chemistry and chemical biology. However, the stringent conditions of the cell environment severely limit the number of accessible metal catalysts and exogenous reactions. Herein, we report an unorthodox approach and a new type of bioorthogonal catalytic reaction, in which a metal complex is an unconventional substrate and an exogenous biological molecule acts as a catalyst. In this reaction, riboflavin photocatalytically converts a Pt

Identifiers

PMID28626570
PMCPMC5471451
OpenAlexW2606007236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.